The search for selective ligands for the CB2 receptor

Area of Science:

• Pharmacology and Medicinal Chemistry
• Cannabinoid Receptor Research

Background:

• The identification of the cannabinoid receptor 2 (CB2) spurred interest in developing selective ligands, as it is primarily found in the periphery.
• Initial research identified cannabimimetic indoles and 1-methoxy-delta8-THC analogues with high affinity for CB2 receptors and low affinity for CB1 receptors.

Purpose of the Study:

• To explore the structure-activity relationships (SAR) of cannabimimetic indoles and 1-deoxy-delta8-THC analogues at the CB2 receptor.
• To synthesize and pharmacologically evaluate novel derivatives of these ligand classes.

Main Methods:

• Synthesis of various derivatives of 3-(1-naphthoyl)indoles and 1-deoxy-delta8-THC analogues with diverse side chains.
• Pharmacological evaluation of synthesized compounds to determine their affinity for CB1 and CB2 receptors.

Main Results:

• Discovery of specific cannabimimetic indoles (L768242, JWH-015) and 1-methoxy-delta8-THC analogues (L759633, L759656) with high CB2 affinity and low CB1 affinity.
• Identification of 1-deoxy-delta8-THC analogues (JWH-051, JWH-057) exhibiting even greater affinity for CB2 receptors compared to CB1 receptors.
• Systematic exploration of SAR for both ligand classes, leading to a series of potent CB2-selective compounds.

Conclusions:

• Significant progress has been made in understanding the SAR for CB2 receptor ligands based on indole and THC analogue scaffolds.
• The ongoing research provides a foundation for the development of novel therapeutics targeting the CB2 receptor.